Evidence map›Paper›PMID 38849332›Full record

ArticleNature communications2024

An effective and rapidly degradable disinfectant from disinfection byproducts.

Jiarui Han, Wanxin Li, Xiangru Zhang

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Elucidating the metabolic pathway and initial degradation gene forApplied and environmental microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jiarui Han *Department of Civil and Environmental Engineering, The Hong Kong University of Science and Technology, Hong Kong SAR, China.ORCID http://orcid.org/0000-0002-5088-9827
Wanxin Li *Department of Civil and Environmental Engineering, The Hong Kong University of Science and Technology, Hong Kong SAR, China.ORCID http://orcid.org/0000-0003-2555-5099
Xiangru ZhangDepartment of Civil and Environmental Engineering, The Hong Kong University of Science and Technology, Hong Kong SAR, China. xiangru@ust.hk.ORCID http://orcid.org/0000-0001-6382-0119

Funding

Research Grants Council, University Grants Committee (RGC, UGC) 16212518
6 · The paper itself

Abstract

Chloroxylenol is a worldwide commonly used disinfectant. The massive consumption and relatively high chemical stability of chloroxylenol have caused eco-toxicological threats in receiving waters. We noticed that chloroxylenol has a chemical structure similar to numerous halo-phenolic disinfection byproducts. Solar detoxification of some halo-phenolic disinfection byproducts intrigued us to select a rapidly degradable chloroxylenol alternative from them. In investigating antimicrobial activities of disinfection byproducts, we found that 2,6-dichlorobenzoquinone was 9.0-22 times more efficient than chloroxylenol in inactivating the tested bacteria, fungi and viruses. Also, the developmental toxicity of 2,6-dichlorobenzoquinone to marine polychaete embryos decreased rapidly due to its rapid degradation via hydrolysis in receiving seawater, even without sunlight. Our work shows that 2,6-dichlorobenzoquinone is a promising disinfectant that well addresses human biosecurity and environmental sustainability. More importantly, our work may enlighten scientists to exploit the slightly alkaline nature of seawater and develop other industrial products that can degrade rapidly via hydrolysis in seawater.

Indexed as

DisinfectantsDisinfectionSeawaterAnimalsBacteriaChlorophenolsFungiHumansHydrolysisPolychaetaVirusesXylenesChlorophenolschloroxylenolDisinfectantsXylenes

Identifiers

PMID38849332
PMCPMC11161644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.